Glycolysis related gene expression signature in predicting prognosis of laryngeal squamous cell carcinoma

References

• Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24(3):379–396.
   PubMed Web of Science ®Google Scholar
• He Y, Liang D, Li D, et al. Incidence and mortality of laryngeal cancer in China, 2015. Chin J Cancer Res. 2020;32(1):10–17.
   PubMed Web of Science ®Google Scholar
• Deng Y, Wang M, Zhou L, et al. Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study. Aging (Albany NY). 2020;12(3):2545–2583.
   PubMedGoogle Scholar
• Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 2019;150:104511.
   PubMed Web of Science ®Google Scholar
• Zheng M, Wang W, Liu J, et al. Lipid metabolism in cancer cells. Adv Exp Med Biol. 2021;1316:49–69.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhang S, Cai Z, et al. A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma. Peer J. 2020;8:e9944.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang Z, Yu Z. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. J Transl Med. 2019;17(1):423.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang S, Bai H, et al. Identification of five glycolysis-related gene signature and risk score model for colorectal cancer. Front Oncol. 2021;11:588811.
   PubMed Web of Science ®Google Scholar
• Chen X, Li Z, Yong H, et al. Trim21-mediated HIF-1alpha degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. Cancer Lett. 2021;508:115–126.
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S. Linking tumor glycolysis and immune evasion in cancer: emerging concepts and therapeutic opportunities. Biochim Biophys Acta Rev Cancer. 2017;1868(1):212–220. [Journal Article; Research Support, U.S. Gov’t, Non-P.H.S.; Review].
   PubMed Web of Science ®Google Scholar
• Sun NY, Yang MH. Metabolic reprogramming and epithelial-mesenchymal plasticity: opportunities and challenges for cancer therapy. Front Oncol. 2020;10:792. [Journal Article; Review].
   PubMed Web of Science ®Google Scholar
• Chakraborty PK, Mustafi SB, Xiong X, et al. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017;8:14634. [Journal Article; Research Support, N.I.H., Extramural].
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Jiang L, et al. Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis. Aging (Albany NY). 2021;13(5):7284–7299.
   PubMedGoogle Scholar
• Zhang Z, Li H, Jiang S, et al. A survey and evaluation of web-based tools/databases for variant analysis of TCGA data. Brief Bioinform. 2019;20(4):1524–1541. [Journal Article; Research Support, Non-U.S. Gov’t; Review].
   PubMed Web of Science ®Google Scholar
• Mo BY, Li GS, Huang SN, et al. The underlying molecular mechanism and identification of transcription factor markers for laryngeal squamous cell carcinoma. Bioengineered. 2021;12(1):208–224. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41( Database issue):D991–5. [Journal Article; Research Support, N.I.H., Intramural].
   PubMed Web of Science ®Google Scholar
• Liberzon A, Birger C, Thorvaldsdottir H, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–425.
   PubMed Web of Science ®Google Scholar
• Chan B. Data analysis using R programming. Adv Exp Med Biol. 2018;1082:47–122.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang YH, Wang S, et al. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS One. 2017;12(9):e184129.
   PubMed Web of Science ®Google Scholar
• The Gene Ontology Consortium. Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res. 2017; 45(D1):D331–8. [Journal Article; Research Support, N.I.H., Extramural]
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–8. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Aguilar PD, Wilson B, Ascha M, et al. New baseline renal function after radical or partial nephrectomy. a simple and accurate predictive model. J Urol. 2020;205(5):1310–1320.
   PubMedGoogle Scholar
• Liu GM, Zeng HD, Zhang CY, et al. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19:138.
   PubMed Web of Science ®Google Scholar
• Chen L, Cai Z, Lyu K, et al. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma. Bioengineered. 2021;12(1):2311–2325. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Mushquash C, O’Connor BP. SPSS and SAS programs for generalizability theory analyses. Behav Res Methods. 2006;38(3):542–547. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Berkman SJ, Roscoe EM, Bourret JC. Comparing self-directed methods for training staff to create graphs using GraphPad prism. J Appl Behav Anal. 2019;52(1):188–204. [Comparative Study; Journal Article].
   PubMed Web of Science ®Google Scholar
• Pond GR, Agarwal N, Bellmunt J, et al. A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma. BJU Int. 2014;113(5b):E137–43. [Journal Article].
   PubMed Web of Science ®Google Scholar
• Machiels JP, Rene LC, Golusinski W, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1462–1475. [Practice Guideline].
   PubMed Web of Science ®Google Scholar
• Shoshani T, Faerman A, Mett I, et al. Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol. 2002;22(7):2283–2293. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Ellisen LW, Ramsayer KD, Johannessen CM, et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell. 2002;10(5):995–1005. [Journal Article; Research Support, Non-U.S. Gov’t; Research Support, U.S. Gov’t, P.H.S.].
   PubMed Web of Science ®Google Scholar
• Foltyn M, Luger AL, Lorenz NI, et al. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br J Cancer. 2019;120(5):481–487. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Wenes M, Shang M, Di Matteo M, et al. Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis. Cell Metab. 2016;24(5):701–715. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Tirado-Hurtado I, Fajardo W, Pinto JA. DNA damage inducible transcript 4 gene: the switch of the metabolism as potential target in cancer. Front Oncol. 2018;8:106.
   PubMed Web of Science ®Google Scholar
• Ding F, Gao F, Zhang S, et al. A review of the mechanism of DDIT4 serve as a mitochondrial related protein in tumor regulation. Sci Prog. 2021;104(1):397402407.
   Web of Science ®Google Scholar
• Qiao S, Koh SB, Vivekanandan V, et al. REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors. Genes Dev. 2020;34(11–12):751–766. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t].
   PubMed Web of Science ®Google Scholar
• Du H, Pang M, Hou X, et al. PLOD2 in cancer research. Biomed Pharmacother. 2017;90:670–676.
   PubMed Web of Science ®Google Scholar
• Qi Y, Xu R. Roles of PLODs in collagen synthesis and cancer progression. Front Cell Dev Biol. 2018;6:66.
   PubMed Web of Science ®Google Scholar
• Du H, Chen Y, Hou X, et al. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC. Cell Death Dis. 2017;8(10):e3143. [Journal Article; Research Support, Non-U.S. Gov’t].
   PubMedGoogle Scholar
• Hu HL, Wang CF, Wei XH, et al. Correlation between procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 and breast cancer. Int J Clin Exp Pathol. 2019;12(3):1015–1021.
   PubMed Web of Science ®Google Scholar
• Du W, Liu N, Zhang Y, et al. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2. Biochem Cell Biol. 2020;98(3):386–395.
   PubMedGoogle Scholar
• Sheng X, Li Y, Li Y, et al. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics. BMC Cancer. 2019;19(1):840.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhou XH, Huang S, et al. Involvement of microRNA-124 in biological behaviors of laryngeal carcinoma via PLOD2 signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(9):4855–4862.
   PubMed Web of Science ®Google Scholar
• Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352(6282):175–180. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t; Research Support, U.S. Gov’t, Non-P.H.S.; Review].
   PubMed Web of Science ®Google Scholar
• Liu Y, Yin S. A novel prognostic index based on the analysis of glycolysis-related genes in head and neck squamous cell carcinomas. J Oncol. 2020 2020-01-01;2020:7353874.
   PubMed Web of Science ®Google Scholar
• Chen L, He X, Yi S, et al. Six glycolysis-related genes as prognostic risk markers can predict the prognosis of patients with head and neck squamous cell carcinoma. Biomed Res Int. 2021 2021-01-01;2021:8824195.
   PubMed Web of Science ®Google Scholar
• Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(9):855–860.
   PubMed Web of Science ®Google Scholar
• Wang N, Lv H, Huang M. Impact of gender on survival in patients with laryngeal squamous cell carcinoma: a propensity score matching analysis. Int J Clin Exp Pathol. 2020;13(3):573–581.
   PubMed Web of Science ®Google Scholar
• Tan S, Duong DT, Westhofen M. Evaluation of gender-specific aspects in quality-of-life in patients with larynx carcinoma. Acta Otolaryngol. 2016;136(12):1201–1205.
   PubMed Web of Science ®Google Scholar
• Atef A, El-Rashidy MA, Elzayat S, et al. The prognostic value of sex hormone receptors expression in laryngeal carcinoma. Tissue Cell. 2019;57:84–89.
   PubMed Web of Science ®Google Scholar